1
Return

Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson’s disease

delete2026-07-07
delete0
PRE
AI
P
Priti Dipa
K
Khadga Raj Aran *
DOI:10.1007/s11011-026-01907-8delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Parkinson’s disease (PD) is a progressive neurodegenerative disease characterised by disruption of brain homeostasis and degeneration of dopaminergic neurons in the substantia nigra. PD is characterised by motor symptoms, like tremor, rigidity, bradykinesia, and postural instability, as well as non-motor symptoms like cognitive impairment, mood disorders, sleep disturbances, and autonomic abnormalities that significantly affect quality of life. The molecular pathogenesis of PD involves Oxidative stress, neuroinflammation, mitochondrial dysfunction, α-synuclein (α-syn) misfolding and aggregation, insufficient autophagy-lysosomal clearance, and synaptic degeneration, leading to progressive neuronal loss. Transthyretin (TTR), a tetrameric transport protein that is primarily produced in the liver and choroid plexus, is well-known for carrying thyroxine and retinol-binding protein. Experimental studies have shown that TTR can protect neurons by binding misfolded proteins, such as α-syn, decreasing toxic aggregation, regulating oxidative stress responses, and affecting selective autophagic degradation. PD-related changes in TTR expression in brain tissue and cerebrospinal fluid provide strong evidence of TTR’s significance as a molecular biomarker and a physiological regulator in the pathogenesis of the disease. This review highlights TTR involvement in neuroinflammation, oxidative stress, and α-syn aggregation, and discusses emerging evidence supporting TTR stabilizers as potential biomarkers and therapeutic targets for modulating disease progression in PD.
Keywords:
Transthyretin
Parkinson’s disease
α-synuclein aggregation
Neuroprotection
Neuroinflammation

Journal

Metabolic Brain Disease cover
Metabolic Brain Disease
IF:
3.5
Papers:
3.2K
Citations:
6.3K

Organization

D
Department of Pharmacy Practice
Scholars:
220
Papers: 94
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers